Omics Lab Services Market Size, Share and Growth Outlook 2026: By Service Type, By Service Format, By Application, By End-User, Companies to 2034
The global Omics Lab Services Market size is forecast to increase from $112.27 Billion in 2026 to $337.74 Billion in 2034 at a CAGR of 14.76% between 2026 and 2034.
The Omics Lab Services market report provides detailed analysis and outlook of Omics Lab Services segments including By Service Type (Genomics Services, Proteomics Services, Transcriptomics Services, Metabolomics Services, Epigenomics Services), By Service Format (Bulk Omics Services, Single-Cell Omics Services), By Application (Clinical Diagnostics, Drug Discovery and Development, Biomarker Discovery, Synthetic Biology), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Diagnostic Laboratories and Reference Labs) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Omics Lab Services Industry Overview
Spatial Biology, Artificial Intelligence, and Multi-Omics Integration Are Transforming Omics Lab Services
The omics lab services industry is rapidly advancing as pharmaceutical companies, biotechnology organizations, and academic research institutions increasingly adopt high-resolution spatial biology, multi-omics profiling, and artificial intelligence-driven analytical platforms. Service providers are expanding beyond conventional sequencing by integrating spatial transcriptomics, proteomics, computational biology, and standardized data frameworks that enable comprehensive characterization of complex biological systems. These developments are accelerating biomarker discovery, precision medicine, drug target identification, and toxicity evaluation while enabling researchers to analyze cellular interactions within their native tissue environments.
Spatial Omics Technologies Expand Research Capabilities
Laboratory service providers are introducing increasingly sophisticated spatial biology workflows to support translational and pharmaceutical research. Vizgen significantly expanded its custom laboratory services by launching volumetric tissue mapping datasets together with pre-designed tissue panels and artificial intelligence-powered cellular segmentation capabilities. These integrated workflows enable pharmaceutical and academic researchers to submit formalin-fixed paraffin-embedded tissue samples for comprehensive single-cell transcriptomic and proteomic profiling while preserving native three-dimensional tissue architecture. The combination of advanced imaging, spatial molecular analysis, and automated computational segmentation provides researchers with highly detailed biological datasets that improve understanding of disease mechanisms and therapeutic responses across diverse research applications.
Artificial Intelligence and Standardized Data Platforms Accelerate Multi-Omics Research
Artificial intelligence and large-scale data standardization are becoming central components of modern omics laboratory services. BGI strengthened its global multi-omics platform through the deployment of Genos, the world's first multi-billion-parameter open-source genomic foundation model, alongside commercial implementation of its Stereo-cell and Stereo-seq V2 spatial transcriptomics technologies. These integrated service platforms enable single-cell mapping of host-microbe interactions while supporting standardized multi-omics data generation through the global 10 Billion Cells Alliance. Complementing these initiatives, BGI-Research published a comprehensive whole-embryo spatial atlas that mapped human organogenesis using high-density spatial transcriptomics to define cellular migration patterns and lineage development. The resulting datasets strengthen biomarker discovery, drug toxicity screening, and precision therapeutic development while supporting the company's commercial sequencing and mass spectrometry laboratory services. Together, these innovations demonstrate the industry's continued evolution toward artificial intelligence-enabled, spatially resolved, and highly standardized omics service platforms.
Omics Lab Services Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Omics Lab Services market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN N.V., Eurofins Scientific SE, BGI Genomics Co., Ltd. (Beijing Genomics Institute), Quest Diagnostics Incorporated, Q2 Solutions LLC (IQVIA), Revvity, Inc., Azenta, Inc. (GENEWIZ Multiomics). The Omics Lab Services market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Omics Lab Services industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Omics Lab Services industry include- Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN N.V., Eurofins Scientific SE, BGI Genomics Co., Ltd. (Beijing Genomics Institute), Quest Diagnostics Incorporated, Q2 Solutions LLC (IQVIA), Revvity, Inc., Azenta, Inc. (GENEWIZ Multiomics). The Omics Lab Services market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Omics Lab Services Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Omics Lab Services market remains one of the strongest-performing segments in the country.
The US Omics Lab Services Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Omics Lab Services market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Omics Lab Services industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Omics Lab Services markets
Canada's strong Omics Lab Services sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Omics Lab Services market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Omics Lab Services Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Omics Lab Services market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Omics Lab Services population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Omics Lab Services industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Omics Lab Services market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Omics Lab Services sales through 2034
France Omics Lab Services companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Omics Lab Services Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Omics Lab Services distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Omics Lab Services Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Omics Lab Services market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Omics Lab Services industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Omics Lab Services industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Omics Lab Services Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Omics Lab Services market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Omics Lab Services market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Omics Lab Services Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Omics Lab Services Market Segmentation
By Service Type
Genomics Services
Proteomics Services
Transcriptomics Services
Metabolomics Services
Epigenomics Services
By Service Format
Bulk Omics Services
Single-Cell Omics Services
By Application
Clinical Diagnostics
Drug Discovery and Development
Biomarker Discovery
Synthetic Biology
By End-User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Diagnostic Laboratories and Reference Labs
Leading Companies in Omics Lab Services Industry (2026)
Thermo Fisher Scientific Inc.
Illumina, Inc.
Agilent Technologies, Inc.
QIAGEN N.V.
Eurofins Scientific SE
BGI Genomics Co., Ltd. (Beijing Genomics Institute)
Quest Diagnostics Incorporated
Q2 Solutions LLC (IQVIA)
Revvity, Inc.
Azenta, Inc. (GENEWIZ Multiomics)
Countries Included
The Omics Lab Services market report provides detailed analysis and outlook of Omics Lab Services segments including By Service Type (Genomics Services, Proteomics Services, Transcriptomics Services, Metabolomics Services, Epigenomics Services), By Service Format (Bulk Omics Services, Single-Cell Omics Services), By Application (Clinical Diagnostics, Drug Discovery and Development, Biomarker Discovery, Synthetic Biology), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Diagnostic Laboratories and Reference Labs) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Omics Lab Services Industry Overview
Spatial Biology, Artificial Intelligence, and Multi-Omics Integration Are Transforming Omics Lab Services
The omics lab services industry is rapidly advancing as pharmaceutical companies, biotechnology organizations, and academic research institutions increasingly adopt high-resolution spatial biology, multi-omics profiling, and artificial intelligence-driven analytical platforms. Service providers are expanding beyond conventional sequencing by integrating spatial transcriptomics, proteomics, computational biology, and standardized data frameworks that enable comprehensive characterization of complex biological systems. These developments are accelerating biomarker discovery, precision medicine, drug target identification, and toxicity evaluation while enabling researchers to analyze cellular interactions within their native tissue environments.
Spatial Omics Technologies Expand Research Capabilities
Laboratory service providers are introducing increasingly sophisticated spatial biology workflows to support translational and pharmaceutical research. Vizgen significantly expanded its custom laboratory services by launching volumetric tissue mapping datasets together with pre-designed tissue panels and artificial intelligence-powered cellular segmentation capabilities. These integrated workflows enable pharmaceutical and academic researchers to submit formalin-fixed paraffin-embedded tissue samples for comprehensive single-cell transcriptomic and proteomic profiling while preserving native three-dimensional tissue architecture. The combination of advanced imaging, spatial molecular analysis, and automated computational segmentation provides researchers with highly detailed biological datasets that improve understanding of disease mechanisms and therapeutic responses across diverse research applications.
Artificial Intelligence and Standardized Data Platforms Accelerate Multi-Omics Research
Artificial intelligence and large-scale data standardization are becoming central components of modern omics laboratory services. BGI strengthened its global multi-omics platform through the deployment of Genos, the world's first multi-billion-parameter open-source genomic foundation model, alongside commercial implementation of its Stereo-cell and Stereo-seq V2 spatial transcriptomics technologies. These integrated service platforms enable single-cell mapping of host-microbe interactions while supporting standardized multi-omics data generation through the global 10 Billion Cells Alliance. Complementing these initiatives, BGI-Research published a comprehensive whole-embryo spatial atlas that mapped human organogenesis using high-density spatial transcriptomics to define cellular migration patterns and lineage development. The resulting datasets strengthen biomarker discovery, drug toxicity screening, and precision therapeutic development while supporting the company's commercial sequencing and mass spectrometry laboratory services. Together, these innovations demonstrate the industry's continued evolution toward artificial intelligence-enabled, spatially resolved, and highly standardized omics service platforms.
Omics Lab Services Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Omics Lab Services market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN N.V., Eurofins Scientific SE, BGI Genomics Co., Ltd. (Beijing Genomics Institute), Quest Diagnostics Incorporated, Q2 Solutions LLC (IQVIA), Revvity, Inc., Azenta, Inc. (GENEWIZ Multiomics). The Omics Lab Services market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Omics Lab Services industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Omics Lab Services Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Omics Lab Services companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Omics Lab Services markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Omics Lab Services industry include- Thermo Fisher Scientific Inc., Illumina, Inc., Agilent Technologies, Inc., QIAGEN N.V., Eurofins Scientific SE, BGI Genomics Co., Ltd. (Beijing Genomics Institute), Quest Diagnostics Incorporated, Q2 Solutions LLC (IQVIA), Revvity, Inc., Azenta, Inc. (GENEWIZ Multiomics). The Omics Lab Services market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Omics Lab Services Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Omics Lab Services market remains one of the strongest-performing segments in the country.
The US Omics Lab Services Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Omics Lab Services market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Omics Lab Services industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Omics Lab Services markets
Canada's strong Omics Lab Services sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Omics Lab Services market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Omics Lab Services Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Omics Lab Services market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Omics Lab Services population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Omics Lab Services industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Omics Lab Services market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Omics Lab Services sales through 2034
France Omics Lab Services companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Omics Lab Services Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Omics Lab Services distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Omics Lab Services Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Omics Lab Services market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Omics Lab Services industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Omics Lab Services industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Omics Lab Services Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Omics Lab Services market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Omics Lab Services market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Omics Lab Services Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Omics Lab Services Market Segmentation
By Service Type
Genomics Services
Proteomics Services
Transcriptomics Services
Metabolomics Services
Epigenomics Services
By Service Format
Bulk Omics Services
Single-Cell Omics Services
By Application
Clinical Diagnostics
Drug Discovery and Development
Biomarker Discovery
Synthetic Biology
By End-User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Diagnostic Laboratories and Reference Labs
Leading Companies in Omics Lab Services Industry (2026)
Thermo Fisher Scientific Inc.
Illumina, Inc.
Agilent Technologies, Inc.
QIAGEN N.V.
Eurofins Scientific SE
BGI Genomics Co., Ltd. (Beijing Genomics Institute)
Quest Diagnostics Incorporated
Q2 Solutions LLC (IQVIA)
Revvity, Inc.
Azenta, Inc. (GENEWIZ Multiomics)
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Omics Lab Services Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Omics Lab Services Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL OMICS LAB SERVICES MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Omics Lab Services Markets in 2026
3.2. Global Historic and Forecast Omics Lab Services Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Omics Lab Services Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Omics Lab Services Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Omics Lab Services Value Chain
CHAPTER 4- OMICS LAB SERVICES MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Omics Lab Services Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- OMICS LAB SERVICES MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Service Type
Genomics Services
Proteomics Services
Transcriptomics Services
Metabolomics Services
Epigenomics Services
By Service Format
Bulk Omics Services
Single-Cell Omics Services
By Application
Clinical Diagnostics
Drug Discovery and Development
Biomarker Discovery
Synthetic Biology
By End-User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Diagnostic Laboratories and Reference Labs
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA OMICS LAB SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Omics Lab Services Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Omics Lab Services Market Trends and Growth Opportunities to 2034
7.5. North America Omics Lab Services Market Size Outlook by Type
7.6. North America Omics Lab Services Market Size Outlook by Application
7.7. North America Omics Lab Services Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Omics Lab Services Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Omics Lab Services Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Omics Lab Services Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Omics Lab Services Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Omics Lab Services Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Omics Lab Services Companies
CHAPTER 8- EUROPE OMICS LAB SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Omics Lab Services Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Omics Lab Services Market Trends and Growth Opportunities to 2034
8.5. Europe Omics Lab Services Market Size Outlook by Type
8.6. Europe Omics Lab Services Market Size Outlook by Application
8.7. Europe Omics Lab Services Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Omics Lab Services Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Omics Lab Services Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Omics Lab Services Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Omics Lab Services Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Omics Lab Services Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Omics Lab Services Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Omics Lab Services Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Omics Lab Services Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Omics Lab Services Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Omics Lab Services Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Omics Lab Services Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Omics Lab Services Companies
CHAPTER 9- ASIA PACIFIC OMICS LAB SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Omics Lab Services Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Omics Lab Services Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Omics Lab Services Market Size Outlook by Type
9.6. Asia Pacific Omics Lab Services Market Size Outlook by Application
9.7. Asia Pacific Omics Lab Services Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Omics Lab Services Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Omics Lab Services Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Omics Lab Services Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Omics Lab Services Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Omics Lab Services Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Omics Lab Services Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Omics Lab Services Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Omics Lab Services Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Omics Lab Services Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Omics Lab Services Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Omics Lab Services Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Omics Lab Services Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA OMICS LAB SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Omics Lab Services Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Omics Lab Services Market Trends and Growth Opportunities to 2034
10.5. South and Central America Omics Lab Services Market Size Outlook by Type
10.6. South and Central America Omics Lab Services Market Size Outlook by Application
10.7. South and Central America Omics Lab Services Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Omics Lab Services Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Omics Lab Services Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Omics Lab Services Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Omics Lab Services Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Omics Lab Services Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Omics Lab Services Companies
CHAPTER 11- MIDDLE EAST AND AFRICA OMICS LAB SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Omics Lab Services Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Omics Lab Services Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Omics Lab Services Market Size Outlook by Type
11.6. Middle East and Africa Omics Lab Services Market Size Outlook by Application
11.7. Middle East and Africa Omics Lab Services Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Omics Lab Services Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Omics Lab Services Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Omics Lab Services Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Omics Lab Services Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Omics Lab Services Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Omics Lab Services Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Omics Lab Services Industry
Thermo Fisher Scientific Inc.
Illumina, Inc.
Agilent Technologies, Inc.
QIAGEN N.V.
Eurofins Scientific SE
BGI Genomics Co., Ltd. (Beijing Genomics Institute)
Quest Diagnostics Incorporated
Q2 Solutions LLC (IQVIA)
Revvity, Inc.
Azenta, Inc. (GENEWIZ Multiomics)
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Omics Lab Services Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Omics Lab Services Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL OMICS LAB SERVICES MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Omics Lab Services Markets in 2026
3.2. Global Historic and Forecast Omics Lab Services Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Omics Lab Services Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Omics Lab Services Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Omics Lab Services Value Chain
CHAPTER 4- OMICS LAB SERVICES MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Omics Lab Services Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- OMICS LAB SERVICES MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Service Type
Genomics Services
Proteomics Services
Transcriptomics Services
Metabolomics Services
Epigenomics Services
By Service Format
Bulk Omics Services
Single-Cell Omics Services
By Application
Clinical Diagnostics
Drug Discovery and Development
Biomarker Discovery
Synthetic Biology
By End-User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Diagnostic Laboratories and Reference Labs
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA OMICS LAB SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Omics Lab Services Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Omics Lab Services Market Trends and Growth Opportunities to 2034
7.5. North America Omics Lab Services Market Size Outlook by Type
7.6. North America Omics Lab Services Market Size Outlook by Application
7.7. North America Omics Lab Services Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Omics Lab Services Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Omics Lab Services Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Omics Lab Services Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Omics Lab Services Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Omics Lab Services Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Omics Lab Services Companies
CHAPTER 8- EUROPE OMICS LAB SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Omics Lab Services Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Omics Lab Services Market Trends and Growth Opportunities to 2034
8.5. Europe Omics Lab Services Market Size Outlook by Type
8.6. Europe Omics Lab Services Market Size Outlook by Application
8.7. Europe Omics Lab Services Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Omics Lab Services Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Omics Lab Services Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Omics Lab Services Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Omics Lab Services Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Omics Lab Services Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Omics Lab Services Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Omics Lab Services Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Omics Lab Services Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Omics Lab Services Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Omics Lab Services Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Omics Lab Services Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Omics Lab Services Companies
CHAPTER 9- ASIA PACIFIC OMICS LAB SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Omics Lab Services Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Omics Lab Services Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Omics Lab Services Market Size Outlook by Type
9.6. Asia Pacific Omics Lab Services Market Size Outlook by Application
9.7. Asia Pacific Omics Lab Services Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Omics Lab Services Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Omics Lab Services Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Omics Lab Services Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Omics Lab Services Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Omics Lab Services Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Omics Lab Services Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Omics Lab Services Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Omics Lab Services Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Omics Lab Services Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Omics Lab Services Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Omics Lab Services Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Omics Lab Services Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA OMICS LAB SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Omics Lab Services Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Omics Lab Services Market Trends and Growth Opportunities to 2034
10.5. South and Central America Omics Lab Services Market Size Outlook by Type
10.6. South and Central America Omics Lab Services Market Size Outlook by Application
10.7. South and Central America Omics Lab Services Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Omics Lab Services Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Omics Lab Services Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Omics Lab Services Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Omics Lab Services Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Omics Lab Services Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Omics Lab Services Companies
CHAPTER 11- MIDDLE EAST AND AFRICA OMICS LAB SERVICES MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Omics Lab Services Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Omics Lab Services Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Omics Lab Services Market Size Outlook by Type
11.6. Middle East and Africa Omics Lab Services Market Size Outlook by Application
11.7. Middle East and Africa Omics Lab Services Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Omics Lab Services Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Omics Lab Services Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Omics Lab Services Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Omics Lab Services Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Omics Lab Services Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Omics Lab Services Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Omics Lab Services Industry
Thermo Fisher Scientific Inc.
Illumina, Inc.
Agilent Technologies, Inc.
QIAGEN N.V.
Eurofins Scientific SE
BGI Genomics Co., Ltd. (Beijing Genomics Institute)
Quest Diagnostics Incorporated
Q2 Solutions LLC (IQVIA)
Revvity, Inc.
Azenta, Inc. (GENEWIZ Multiomics)
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
